Experience with the use of basiliximab in liver transplantation-use in pediatric and adult recipients in combination with cyclosporine or tacrolimus

By Petz W.   Spada M.   Bertani A.   Lucianctti A.   Casagrande F.   Guizzetti M.   Corno V.   Colledan M.   Strazzabosco M.   Gridelli B.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1966-1967

Elsevier

Access to resources Recommend Favorite

Experience with basiliximab in pediatric renal transplantation

By Vilalta R.   Vila A.   Nieto J.   Espanol T.   Caragol I.   Calls L.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 100-101

Elsevier

Access to resources Recommend Favorite

Basiliximab reduces acute liver allograft rejection in pediatric patients

By Strassburg A.   Pfister E.-D.   Arning A.   Nashan B.   Ehrich J.H.H.   Melter M.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2374-2375

Elsevier

Access to resources Recommend Favorite

Immunoprophylaxis with simulect (Basiliximab) in pediatric kidney transplant recipients: results from routine clinical practice at 5 kidney transplant units

By Garcia Meseguer C.   Vila Lopez A.   Luque de Pablos A.   Vallo Boado A.   Simon J.M.   Pediatric EOSS Study Group  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1697-1698

Elsevier

Access to resources Recommend Favorite

Duration of action of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in pediatric kidney transplant recipients

By Sterkers G.   Baudouin V.   Ansart-Pirenne H.   Maisin A.   Niaudet P.   Cochat P.   Loirat C.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2757-2759

Elsevier

Access to resources Recommend Favorite